Results 101 to 110 of about 412,643 (184)

Comparison of Pharmacokinetics and Pharmacodynamics of Inhaled Technosphere Insulin and Subcutaneous Insulin Lispro in the Treatment of Type 1 Diabetes Mellitus. [PDF]

Clin Pharmacokinet, 2022
Grant M, Heise T, Baughman R.
europepmc   +1 more source

Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy

, 2004
Aim To determine the rate of major congenital anomalies in offspring of a large group of women with diabetes mellitus treated with insulin lispro (Humalog®). Methods This multinational, multicentre, retrospective study included mothers with diabetes
J. L. FRIAS, H. E. HOYME, L. KERR, R. KAAJA, V. MATTOO, NAPOLI, Angela, A. LEE PARRITZ, E. W. SEELY, L. JOVANOVIC, F. BROWN, S. GARG, J. W. WYATT   +11 more
core   +1 more source

Satisfaction, Preference and Injection Habits of Switching to 200 Units/ml Insulin Lispro Pen from 100 Units/ml: A Patient Survey in Germany. [PDF]

Diabetes Ther, 2021
Chen J, Williams P, Perez-Nieves M, Piras De Oliveira C, Spaepen E, Osumili B, Poon JL, Schloot NC, Thun B, Blüher M.   +9 more
europepmc   +1 more source

Use of Diluted Rapid-Acting Insulin in the Minimed™ 780G Automated Insulin Delivery System in a Young Child with Type 1 Diabetes

Clinical Diabetology
The MiniMed™ 780G automated insulin delivery (AID) system improves glycemic control in type 1 diabetes (T1D), but Auto Mode requires a total daily insulin dose (TDI) ≥8 U, limiting its use in young children or individuals in the honeymoon phase.
Sebastian Seget, Julia Maria Stadnik, Mateusz Tarasiewicz, Ewa Rusak, Sebastian Sirek, Barbara Trepka-Sirek, Przemysława Jarosz-Chobot   +6 more
doaj   +1 more source

Effects of Regular Insulin or Insulin Lispro on Glucose Metabolism after an Oral Glucose Load in Patients with Type 2 Diabetes Mellitus

, 1998
peer reviewedSeven obese Type 2 diabetic patients were studied for two 4-h periods after ingestion of a glucose load to determine the effects of preprandial subcutaneous injection of Insulin Lispro (5 min before the meal) or regular insulin (20 min ...
Pahud, P., Roulin, D., Paquot, Nicolas, Schneiter, P., Ruiz, J., Tappy, L., Lefèbvre, Pierre   +6 more
core   +3 more sources

Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus

International Journal of General Medicine, 2011
Candis M Morello1,21Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 2School of Pharmacy, University of California San Francisco, Veterans Affairs San Diego Healthcare System, San Diego, CA, USAIntroduction: The ...
Morello CM
doaj  

Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial.

JAMA, 2023
Rosenstock J, Frías JP, Rodbard HW, Tofé S, Sears E, Huh R, Fernández Landó L, Patel H.   +7 more
europepmc   +1 more source

Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs Humalog^® Consistently Across Study Populations: A Pooled Analysis of Pharmacokinetic and Glucodynamic Data. [PDF]

Clin Pharmacokinet, 2021
Leohr J, Dellva MA, Carter K, LaBell E, Linnebjerg H.   +4 more
europepmc   +1 more source

Fasting and postprandial plasma glucose contribution to glycated haemoglobin and time in range in people with type 2 diabetes on basal and bolus insulin therapy: Results from a pooled analysis of insulin lispro clinical trials. [PDF]

Diabetes Obes Metab, 2021
Liao B, Chen Y, Chigutsa F, Piras de Oliveira C.   +3 more
europepmc   +1 more source

Insulin Lispro: A Pharmacoeconomic Review of its Use in Diabetes Mellitus

Insulin lispro is a recombinant insulin analogue with transposed amino acids (proline and lysine) at positions 28 and 29 near the C-terminus of the B-chain.
Greg L. Plosker, Christopher J. Dunn
core